Filing search / Nkarta, Inc. / "Department of"

8-K

EX-1.1

NKTX Nkarta, Inc.

28 Mar 24

Other Events

4:08pm

and Drug Administration of the U.S. Department of Health and Human Services (“FDA”) or comparable federal, state, local or foreign governmental bodies … ”) that is, or is owned or controlled by a Person that is: (i) the subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office

8-K

EX-99.1

aawckh 28pz2

17 Oct 23

Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis

7:06am

PRE 14A

ajphlfd vmku9jw2yz

14 Apr 23

Preliminary proxy

5:00pm

8-K

EX-1.1

1hbpp kp0

28 Apr 22

Other Events

4:20pm

S-3

EX-1.2

882mh awptcqen

12 Aug 21

Shelf registration

5:04pm

8-K

EX-10.1

7lmyrpva5a4f

14 Jul 21

Entry into a Material Definitive Agreement

7:07am

DEF 14A

ccjh04 nuz

22 Apr 21

Definitive proxy

12:35pm

10-K

2r415f1f

25 Mar 21

Annual report

12:00am

8-K

EX-10.1

ycz veik6y10s0y2mp8

5 Oct 20

Nkarta Announces Leadership Changes

4:15pm